| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $363.7M | +3.3% | +2.9% |
| Cost of Revenue | $53.2M | +8.5% | -0.2% |
| R&D Expense | $15.4M | -6.5% | +1.0% |
| SG&A Expense | $54.0M | -0.1% | -46.9% |
| Operating Income | $28.4M | -15.1% | +197.0% |
| Pre-tax Income | $9.1M | -64.2% | +125.4% |
| Income Tax | $12.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $503.4M | +10.1% | +30.4% |
| Accounts Receivable | $473.2M | -9.5% | +0.6% |
| Current Assets | $1.12B | +2.0% | +18.2% |
| Total Assets | $3.48B | -1.2% | +1.7% |
| Current Liabilities | $698.0M | +0.7% | +4.6% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $216.0M | — | — |
| Capital Expenditures | $85.9M | — | — |
| Investing Cash Flow | -$116.4M | — | — |
| Financing Cash Flow | -$111.5M | — | — |
| Free Cash Flow | $130.1M | — | — |
| +198.1% |
| +1.9% |
| Net Income | -$3.6M | -113.7% | +92.6% |
| EPS (Basic) | -$0.09 | -114.3% | +91.9% |
| EPS (Diluted) | -$0.09 | -114.5% | +91.9% |
| $865.9M |
| +0.1% |
| +0.3% |
| Total Liabilities | $1.68B | +0.1% | +0.7% |
| Stockholders' Equity | $1.80B | -2.4% | +2.7% |